Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 18093 matches for

Cannabis intoxication triggers cognitive mechanism of addiction

New research has found that the main component of cannabis, delta-9-tetrahydrocannabinol (THC), leads to people’s attention being more drawn to other cannabis stimuli when using the drug.

Tackling mental illness by supporting industry to develop new drugs

An academic/industry partnership, based at the NIHR Oxford Health Biomedical Research Centre, is helping companies use experimental medicine approaches to speed up development of new drugs to treat psychiatric disorders.

MSc in Clinical and Therapeutic Neuroscience student prizes announced

The academic standard of the 2022/23 cohort was extremely high with two students getting special recognition.

Artificial intelligence (AI) language tools could be used to help detect mental health conditions

Scientists are using AI to detect language differences in people with mental health difficulties that could eventually be used to help diagnose and monitor psychiatric conditions.

Alan Stein retires as Chair of Child and Adolescent Psychiatry

Professor Alan Stein, Chair of Child and Adolescent Psychiatry, is retiring from Oxford’s Department of Psychiatry and will be taking up a senior post at the Blavatnik School of Government in global health and public policy.

Response to study on esketamine nasal spray

Leading Oxford consultant psychiatrist Rupert McShane has responded to a new paper on the effectiveness of esketamine nasal spray, a form of ketamine, for treatment-resistant depression.

Husseini Manji awarded international prize in mental health

Professor Manji is one of the recipients of the 2023 Rhoda and Bernard Sarnat International Prize in Mental Health for the discovery of the rapid antidepressant effects of ketamine.

'There's never been a more difficult time to be young'

Researchers from Oxford, Kent, Falmouth, London and Leeds came to together to address the complexities of adolescent mental health at the Attune conference.

New MND Accelerator to facilitate the development of treatments for Motor Neuron Disease.

£6 million experimental medicine programme aims to make the translation of discoveries into therapeutics easier.

New tool to streamline prescribing of antidepressants

A new web tool has been developed to simplify the prescription of antidepressant and antipsychotic drugs.

Advice on chronic pain for young people

A new video produced by young people offers advice on living with chronic pain.

Photo exhibition highlights experiences of detention under Mental Health Act

An online and in person photo exhibition displayed in London and Manchester will detail the experiences of diverse people detained under the Mental Health Act.

Young people’s mental health deteriorated at greater rate during the pandemic

Major new study shows young people’s mental health deteriorated during COVID-19, with higher levels of depression and social, emotional and behavioural difficulties than before the pandemic hit.

Response to Suicide Prevention Strategy

Director of the Centre for Suicide Research Keith Hawton responds to publication of the government's Suicide Prevention Strategy for England.

Blood clots during COVID-19 may be a cause of ongoing cognitive problems

High levels of two proteins at the time of COVID-19 have been found in patients who later experienced cognitive problems, including ‘brain fog'.

New dementia risk score helps identify people at risk

The UK Biobank Dementia Risk Score, or UKBDRS for short, outperformed three other widely used risk scores when identifying people at risk of developing dementia.

High premature mortality in those given community sentences who had psychiatric or substance use disorders

People who had mental health or substance use disorders when they were given community orders were three times more likely to die prematurely, and particularly from suicide, accidents, drug overdose, or homicide, compared to those without any psychiatric diagnoses.

Prioritising the children of parents with severe mental illness

The needs of children whose parents have severe mental illness should be prioritised, according to a new paper written by a consortium of international experts.

'Ketamine may offer hope for treatment-resistant depression'

Oxford University and Oxford Health NHS Foundation Trust consultant psychiatrist Professor Rupert McShane is calling for ketamine to be used as an option for those patients with severe or very treatment resistant depression being considered for Electroconvulsive Therapy (ECT).

Routine brain scanning may improve clinical care for people with psychosis

Routine brain scanning in people experiencing psychosis could help to identify underlying physical conditions that are causing their symptoms, according to a new study.

Load More